Paris Based Cellectis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

By Ben Otto British drugmaker AstraZeneca plans to invest $245 million in a deal with biotechnology company Cellectis to develop next-generation therapeutics.

United kingdomBen ottoParis based cellectisArticle normalBiotechnology servicesHealthcare life sciencesResearch developmentCorporate industrial newsAlcls frFr alclsAzn lnUk aznIndustrial newsLife sciences